Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy

NCT04124510 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped The Contract of K-haler products had been terminated between Mundipharma and provider. Therefore, this clinical trial was terminated early.

Conditions

Interventions

Sponsor

Mundipharma Korea Ltd